| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/28/2023 | 16.75% | Raymond James | $98 → $115 | Upgrades | Outperform → Strong Buy |
| 10/20/2023 | 11.68% | Raymond James | → $110 | Upgrades | Market Perform → Outperform |
| 10/04/2023 | — | OTR Global | Downgrades | Positive → Mixed | |
| 09/19/2023 | 35.03% | Wedbush | → $133 | Reiterates | Outperform → Outperform |
| 09/07/2023 | 2.54% | B. Riley Securities | $125 → $101 | Downgrades | Buy → Neutral |
| 08/01/2023 | 35.03% | Wedbush | → $133 | Reiterates | Outperform → Outperform |
| 07/28/2023 | 31.98% | Stifel | → $130 | Upgrades | Hold → Buy |
| 07/27/2023 | 55.33% | Wedbush | → $153 | Reiterates | Outperform → Outperform |
| 07/24/2023 | 55.33% | Wedbush | → $153 | Reiterates | Outperform → Outperform |
| 07/13/2023 | 55.33% | Wedbush | → $153 | Reiterates | Outperform → Outperform |
| 06/14/2023 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 04/28/2023 | 61.42% | B. Riley Securities | $157 → $159 | Maintains | Buy |
| 04/28/2023 | 87.82% | Baird | $175 → $185 | Maintains | Outperform |
| 04/21/2023 | 52.28% | Stifel | $133 → $150 | Maintains | Hold |
| 04/17/2023 | — | OTR Global | Upgrades | Mixed → Positive | |
| 02/17/2023 | 35.03% | Stifel | $107 → $133 | Maintains | Hold |
| 02/17/2023 | 77.66% | Baird | $155 → $175 | Maintains | Outperform |
| 01/12/2023 | 25.89% | UBS | $107 → $124 | Maintains | Neutral |
| 01/12/2023 | 47.21% | Piper Sandler | $118 → $145 | Maintains | Overweight |
| 01/11/2023 | 57.36% | Baird | $150 → $155 | Maintains | Outperform |
| 12/16/2022 | 19.8% | Piper Sandler | $95 → $118 | Maintains | Overweight |
| 11/14/2022 | 52.28% | Baird | $100 → $150 | Maintains | Outperform |
| 11/04/2022 | 1.52% | Baird | $95 → $100 | Maintains | Outperform |
| 09/21/2022 | — | Exane BNP Paribas | Initiates Coverage On | → Neutral | |
| 07/15/2022 | -40.1% | UBS | $73 → $59 | Maintains | Neutral |
| 07/05/2022 | -23.86% | Loop Capital | → $75 | Upgrades | Hold → Buy |
| 04/29/2022 | -8.63% | Wedbush | → $90 | Initiates Coverage On | → Outperform |
| 04/04/2022 | -18.78% | Loop Capital | $150 → $80 | Downgrades | Buy → Hold |
| 02/01/2022 | 52.28% | Loop Capital | $190 → $150 | Maintains | Buy |
| 01/26/2022 | 55.33% | B. Riley Securities | $174 → $153 | Maintains | Buy |
| 01/18/2022 | — | Seaport Global | Initiates Coverage On | → Neutral | |
| 09/15/2021 | 76.65% | B. Riley Securities | $152 → $174 | Maintains | Buy |
| 07/22/2021 | 87.82% | Piper Sandler | $143 → $185 | Maintains | Overweight |
| 07/20/2021 | 31.98% | Pivotal Research | $125 → $130 | Maintains | Buy |
| 07/14/2021 | 45.18% | Piper Sandler | $140 → $143 | Maintains | Overweight |
| 06/29/2021 | 34.01% | B. Riley Securities | $113 → $132 | Maintains | Buy |
| 04/27/2021 | 42.13% | Piper Sandler | $104 → $140 | Maintains | Overweight |
| 02/24/2021 | 1.52% | Pivotal Research | $92 → $100 | Maintains | Buy |
| 10/27/2020 | -31.98% | Piper Sandler | $53 → $67 | Maintains | Overweight |
| 10/19/2020 | -51.27% | UBS | $42 → $48 | Maintains | Neutral |
| 10/14/2020 | -46.19% | Piper Sandler | $48 → $53 | Maintains | Overweight |
| 09/29/2020 | -51.27% | Piper Sandler | $46 → $48 | Maintains | Overweight |
| 08/25/2020 | -53.3% | B. Riley Securities | $35 → $46 | Upgrades | Neutral → Buy |
| 07/22/2020 | -59.39% | UBS | → $40 | Initiates Coverage On | → Neutral |
| 07/17/2020 | — | CL King | Downgrades | Buy → Neutral | |
| 06/30/2020 | -59.39% | Loop Capital | $22 → $40 | Upgrades | Hold → Buy |
| 04/06/2020 | -74.62% | Susquehanna | $51 → $25 | Maintains | Positive |
| 02/28/2020 | -56.35% | Baird | $49 → $43 | Maintains | Outperform |
| 10/08/2019 | -65.48% | Piper Sandler | $32 → $34 | Maintains | Overweight |
| 08/02/2019 | -76.65% | Stifel | $21 → $23 | Maintains | Hold |
| 07/15/2019 | -72.59% | Piper Sandler | $22 → $27 | Upgrades | Neutral → Overweight |
| 06/21/2019 | -70.56% | Baird | → $29 | Upgrades | Neutral → Outperform |
| 04/23/2019 | -68.53% | Piper Sandler | → $31 | Downgrades | Overweight → Neutral |
| 01/02/2019 | — | Susquehanna | Upgrades | Neutral → Positive |
What is the target price for Crocs (CROX)?
The latest price target for Crocs (NASDAQ: CROX) was reported by Raymond James on November 28, 2023. The analyst firm set a price target for $115.00 expecting CROX to rise to within 12 months (a possible 16.75% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Crocs (CROX)?
The latest analyst rating for Crocs (NASDAQ: CROX) was provided by Raymond James, and Crocs upgraded their strong buy rating.
When is the next analyst rating going to be posted or updated for Crocs (CROX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crocs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crocs was filed on November 28, 2023 so you should expect the next rating to be made available sometime around November 28, 2024.
Is the Analyst Rating Crocs (CROX) correct?
While ratings are subjective and will change, the latest Crocs (CROX) rating was a upgraded with a price target of $98.00 to $115.00. The current price Crocs (CROX) is trading at is $98.50, which is within the analyst's predicted range.